X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.85 -0.06 (-1.90%)
As of: Oct 1, 2026 · 10:47 AM EDT

X4 Pharmaceuticals (XFOR) Other Non-Current Liabilities (2017 - 2026)

Updated

X4 Pharmaceuticals' Other Non-Current Liabilities was $523,000 in Q2 2026, down 2.2% from $535,000 a year earlier and down 41.7% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at X4 Pharmaceuticals came in at $977,000, down 92.9% from FY2024.

  • Other Non-Current Liabilities has now declined for three consecutive years, though with a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Liabilities was $13.76 million in FY2024 (-12.3%), $15.68 million in FY2023 (-32.2%), $23.13 million in FY2022 and $826,000 in FY2021 (+78.8%).
  • The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q3 2022.
  • Compared with a year earlier, Other Non-Current Liabilities has declined for nine straight quarters, with an average decline of 62.8% over the last eight quarters.
  • The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2021 (growth of 78.8%); the worst was Q2 2025 (a decline of 94.2%).
  • Per Business Quant data, XFOR's Other Non-Current Liabilities in the three quarters before Q2 2026 was $897,000 (Q1 2026), $977,000 (Q4 2025) and $959,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 X4 Pharmaceuticals 366.40 Mn -332.29 Mn 7.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 523,000.00
Mar 31, 2026 897,000.00
Dec 31, 2025 977,000.00
Sep 30, 2025 959,000.00
Jun 30, 2025 535,000.00
Mar 31, 2025 2.93 Mn
Dec 31, 2024 13.76 Mn
Sep 30, 2024 11.09 Mn
Jun 30, 2024 9.22 Mn
Mar 31, 2024 29.44 Mn
Dec 31, 2023 15.68 Mn
Sep 30, 2023 22.01 Mn
Jun 30, 2023 47.18 Mn
Mar 31, 2023 17.69 Mn
Dec 31, 2022 23.13 Mn
Sep 30, 2022 312,000.00
Jun 30, 2022 314,000.00
Mar 31, 2022 650,000.00
Dec 31, 2021 826,000.00
Sep 30, 2021 496,000.00
API Access

X4 Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=XFOR&period=max&api_key=YOUR_API_KEY